Shares of the cannabis company are likely to drift lower in the weeks ahead.
Singer teamed up with company this week, sending its stock on a wild ride.
A cautious approach by the state is having a wicked effect on earnings and estimates.
Several watchers and market players are deep in the weeds, tracking short action and key companies like Canopy Growth, trying to find out whether the industry has turned over a new leaf.
Is this cannabis name a long-term winner or a one-hit wonder?
Let's check out the charts and indicators to see if they are growing fast too.
Cannabis companies -- like any other firm -- rely on software to help handle sales and the keep the books in order, and it turns out just five are dominant players in the scene.
A host of other cannabis-related stocks has sprouted up that appear better for investing.
After a 2018 high, marijuana stocks are gaining popularity again, but which ones are producing the most green for investors? Here are the charts.
The largest impediment to success for firms like TLRY -- which is expected to report a 27 cent loss per share Tuesday night -- remains federal legalization of marijuana across the U.S.
Agency has the authority to carve out an exception to existing laws.
Tilray will look to sustain a sanguine sentiment on cannabis stocks on Tuesday.
There has been some recent consolidation and accumulation in the cannabis stock that could be setting the stage for an upside move.
Illogical action likely driven by an exchange-traded fund on this cannabis company shows how both the Efficient Market Hypothesis and irrationality can co-exist.
Let's see how the charts of GWPH are shaping up.
Aurora is trying to ride the momentum of Aphria's earnings report and jump in front of other potential strong reports.
The charts of the cannabis producer indicate that its shares have found a support level.
I think Aphria is starting to show its potential.
There is no technical reason to go long on beleaguered CTST, and it has not created a bottom, yet.
Following growing scandal, CannTrust Holdings is luring bargain shoppers as the stock moves higher after the company announced it's considering selling itself.
The cannabis company's $4 billion market cap continues to dominate the sector without enough reason.
So many stocks, so much news, so little time. The good news is I'm letting you borrow my shovel.
The charts make ZYNE look bearish and not particularly attractive, so avoid.
The shelf offering isn't a risk. Not having access to it was.
Be sure your cannabis investments have the right CBD strategy, as the market for these products takes off.
This is a bullish market that -- rather than celebrating a dovish Fed and new highs -- fears missing out.
The loss of clients is a primary concern here.
Let's look at the chart of CRON.
The business continues to churn forward as the company announced it has achieved a full run-rate production of 75K kg at its Delta 3 greenhouse.
A cannabis-related REIT soared 172% in the first half of the year while a cloud services provider was up 53%, with more gains expected.